Request Demo
Last update 08 May 2025
MDI-1228
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms MDI-1228_mesylate + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with MDI-1228NCT06852976
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
CTR20233049
评价MDI-1228_mesylate凝胶在成人轻、中度特应性皮炎患者中多次局部外用给药的安全性和有效性的剂量递增、随机、双盲、安慰剂对照的Ⅱ期临床试验
[Translation] A dose-escalating, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the safety and efficacy of multiple topical administrations of MDI-1228_mesylate gel in adult patients with mild to moderate atopic dermatitis
ChiCTR2300076566
To evaluate the safety and efficacy of multiple topical administration of MDI-1228_mesylate gel in adult patients with mild to moderate atopic dermatitis, a phase ?, dose-escalation, randomized, double-blind, placebo-controlled clinical trial.
100 Clinical Results associated with MDI-1228
Login to view more data
100 Translational Medicine associated with MDI-1228
Login to view more data
100 Patents (Medical) associated with MDI-1228
Login to view more data
100 Deals associated with MDI-1228
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic foot ulcer | Phase 2 | United States | 12 Mar 2025 | |
| Dermatitis, Atopic | Phase 2 | China | 17 Oct 2023 | |
| Conjunctivitis, Allergic | Phase 1 | Australia | 06 Oct 2023 | |
| Psoriasis | IND Approval | China | 14 Mar 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free